Certara (Pharsight): Phoenix/WinNonlin licensing policy [Software]

posted by Lucas – Brazil, 2015-07-20 21:32 (3495 d 10:16 ago) – Posting: # 15111
Views: 21,021

Hello guys.

Yep, I also receive this news recently, when I was speaking with Certara's agent in South America. They've increased the price considerably with this new policy, and they may lose market due to that. I do think Phoenix is a great software for BA/BE and use it now for many years, but IMHO this is a very risky strategy for them. We use here the floating licenses, that could be used in any computer connected to our server, one user per license but could be any user... Small CROs will be indeed squeezed. The license fee will be cheaper than this extra fee. And also, don't know how they'll account for the studies conducted, but CROs sometimes uses the software with investigational non commercial purposes... I wonder if those will count.
May be time to improve my R "almost non-existing" skills! :-D

Lucas

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
32 visitors (0 registered, 32 guests [including 5 identified bots]).
Forum time: 06:48 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5